ArticleKidney international reports2026

Combined Anti-CD20 and/or Anti-CD38 Therapy in Recurrent FSGS: Results Before Reasons.

Paolo Cravedi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.